Σύγκριση μεθόδων

	Κριτήρια West Haven για Ηπατική Εγκεφαλοπάθεια	Βαθμολογία Mayo για ελκώδη κολίτιδα
Πεδίο	Γαστρεντερολογία	Γαστρεντερολογία
Οικογένεια	Process / pipeline	Process / pipeline
Έτος προέλευσης	1966 (original), 1978 (formalized)	1987
Δημιουργός	West Haven Group (Parsons, Williams, Sherlock, Trey, Davidson)	Schroeder, K. W., Tremaine, W. J., and Ilstrup, D. M.
Τύπος	Clinician-rated	Clinician-rated
Θεμελιώδης πηγή	Parsons, P. L., Williams, R., & Sherlock, S. (1978). The role of plasma amino acids in hepatic encephalopathy and the effect of branched-chain amino acid infusion. Gut, 19(10), 969–978.	Schroeder, K. W., Tremaine, W. J., & Ilstrup, D. M. (1987). Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. New England Journal of Medicine, 317(26), 1625–1629.
Εναλλακτικές ονομασίες	Hepatic Encephalopathy Grading, HE Grade, West Haven Grade	Mayo Clinic Score, UC Mayo Score
Συναφείς	4	4
Σύνοψη	The West Haven Criteria are the standard for grading hepatic encephalopathy (HE) severity, ranging from subclinical (Grade 0) to deep coma (Grade 4). Developed by Trey and Davidson in the 1960s and refined by the West Haven group, these criteria integrate mental status changes (confusion, asterixis, disorientation) and consciousness level to stage HE. The West Haven grade is a strong predictor of short-term prognosis in cirrhosis and guides urgency of intervention (lactulose, rifaxomicin, mannitol, intubation).	The Mayo Score is a validated tool for assessing disease activity in ulcerative colitis, integrating clinical symptoms and endoscopic findings. Introduced by Schroeder and colleagues in 1987, it has become the reference standard for UC activity assessment in clinical trials and practice. The score combines stool frequency, rectal bleeding, overall physician global assessment, and endoscopic subscore into a single 0–12 scale.